Skip to main content

Table 1 Demographical and clinical information of BD responder (R) and non-responder (NR) patients

From: Transcriptomics and miRNomics data integration in lymphoblastoid cells highlights the key role of immune-related functions in lithium treatment response in Bipolar disorder

 

R

(n = 11)

NR

(n = 9)

Age (mean ± SD)

49.06 ± 12.51

45.81 ± 6.62

Sex (M/F)

6/5

6/3

Ethnicity

Caucasian

Caucasian

Smoking (yes/no)

6/5

5/4

Age of onset (mean ± SD)

27.91 ± 9.78

29.67 ± 10.22

N° of lifetime mood episodes (mean ± SD)

7.09 ± 4.89

11.29 ± 5.79

ALDA total score (mean ± SD)

8.27 ± 1.01

1,89 ± 1.27

CTQ total score (mean ± SD)

38.55 ± 7.54

41.56 ± 10.70

Medication (yes/no)

 - Lithium

9/2

5/4

 - Atypical antipsychotics

1/10

6/3

 - Anticonvulsants

2/9

4/5